Colombia – MJ Shareholders https://mjshareholders.com The Ultimate Marijuana Business Directory Tue, 12 Sep 2023 20:41:05 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.3 One World Products, Inc. Partners With Smokiez Edibles for Potential $20 Million Annual Revenue in Colombia and Millions More Globally https://mjshareholders.com/one-world-products-inc-partners-with-smokiez-edibles-for-potential-20-million-annual-revenue-in-colombia-and-millions-more-globally/ Tue, 12 Sep 2023 20:41:05 +0000 https://cannabisfn.com/?p=2974052

Ryan Allway

September 12th, 2023

News, Top News


Secures Exclusive Production and Distribution of Smokiez Gummies in Colombia With Additional Global Expansion

LAS VEGAS, NV, Sept. 12, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — In a strategic move to amplify their global presence, One World Products, Inc. (“OWP”) (OTCQB: OWPC), the largest Black-controlled, fully-licensed hemp and cannabis producer in Colombia and a dominant entity in the hemp and cannabis production industry, has announced an exclusive collaboration with Smokiez Edibles. Through this significant partnership, OWP will become the singular producer and distributor of the widely-acclaimed Smokiez Gummies in the Colombian territory.

Building on this synergistic alliance, One World Products will be leveraging its top-notch facilities within the Colombian Free Trade Zone to manufacture and distribute the sought-after Smokiez Gummies to the vast Asian, South American, and European markets. This dual-pronged strategy will be an instrumental step for both companies in broadening their global outreach and establishing a firmer foothold in pivotal international markets.

Isiah Thomas, Chairman, and CEO of One World Products, Inc., expressed his enthusiasm for the venture: “This partnership marks a monumental chapter in One World Products’ growth narrative. Smokiez unparalleled reputation for their vegan edibles is precisely the kind of innovation we want to introduce to our markets. Our state-of-the-art facilities in the Colombian Free Trade Zone, coupled with Smokiez product excellence, places us in a prime position to cater to and captivate global audiences.”

Ryan Wright, Co-Founder of Smokiez Edibles, added, “One World Products is an industry partner that aligns perfectly with Smokiez ethos and aspirations. Considering our strong market presence, especially as top-selling edibles in regions like New York, Oklahoma, Missouri, and Arkansas, our alliance with OWP is a calculated step to further enhance our global reach and reinforce our commitment to delivering unparalleled edible experiences worldwide.”

About Smokiez Edibles

With its roots in Portland, Oregon, and originating in 2010, Smokiez Edibles is a family-driven endeavor renowned for its delectable vegan edibles. Their unyielding commitment to product quality has helped grow them into the edible brand with the largest footprint in the U.S., currently active in 17 states with 3 additional states scheduled to come online in the coming months. With licenses across multiple states from Oregon to Puerto Rico, their expanding portfolio is a testament to their vision and innovation.

Their accolades, such as 1st Place at the 2022 High Times Colorado Cannabis Cup and the 2022 Cannabyss Hub Award for Best Gummy of the Year, further underline their industry dominance.

About One World Products, Inc. (OTCQB: OWPC)

One World Products is the largest Black-controlled, fully licensed hemp and cannabis producer with offices in Las Vegas, Nevada, and offices and operations in Bogota and Popayan, Colombia. One World Products planted its first crop of cannabis in 2018 at its cultivation site in Popayan, Colombia, and began harvesting commercially in the first quarter of 2020.

As an ascendant international hemp and cannabis company focused on environmental, social, and governance (ESG) standards, the recently announced Isiah International/One World Products/AMUNAFRO consortium controls approximately 1.2 million acres of land in Colombia focused on the licensed production of industrial hemp for integration into sustainable, carbon-reducing products made throughout the world. The Company expects to supply its global clients with the highest quality industrial and commercial applications for cannabis, hemp, and hemp products, including derivatives in crude oil, distillate, and isolate forms with industrial-scale production to serve global cannabis and hemp demand. Its products will be produced and tested according to GAP, GMP and ISO standards.

For more information, please visit https://oneworldproducts.com/#HempIsTheNewPlastic (TM)

About Isiah Thomas and ISIAH International, LLC

Isiah Thomas was inducted into the National Basketball Association (NBA) Hall of Fame in 2000 after spending his entire career with the Detroit Pistons. He was a 12-time NBA All-Star, a two-time NBA champion, the 1990 NBA Finals Most Valuable Player, and named as one of the 50 Greatest Players in NBA History. Today, Mr. Thomas serves as an analyst for NBA TV and is an accomplished and highly respected international business executive and investor. His portfolio of companies was developed through Isiah International, Inc., which invests in companies with strong market positions and growth potential.

Mr. Thomas’ business interests include sports and entertainment, real estate, waste management, hemp, cannabis, and a CBD personal products company, among others. In addition, Mr. Thomas has developed a very successful champagne business, Cheurlin Champagnes. He has cultivated excellent relationships with the grower, employees, and the French government. As a result, he now owns the proprietary genetics for the Champagne grapes he produces and has perfected an international import/export system for the global distribution of the product. More information is available at www.isiahinternational.com.

Mr. Thomas previously served on the Chicago Stock Exchange’s Board of Governors, was a co-founder of the NBA’s Toronto Raptors, Popcorn Indiana, and was a member of the Board of Get-in Chicago, an organization that focused on preventing gang violence in Chicago. He is a Distinguished Alumnus of Indiana University, where he earned his Bachelor of Arts in Criminal Justice. He also received his Master of Education from the University of California at Berkeley.

Forward-Looking Statements:

This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential,” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (“SEC”), including the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at www.sec.gov.

All forward-looking statements speak only as of the date on which they are made. The Company undertakes no obligation to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement was made, except to the extent required by applicable securities laws.

Investor Contact:

ClearThink IR
bloper@clearthink.capital
602-785-4120

Source: One World Products, Inc.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
Flora Growth Begins Product Sales in Juan Valdez, Colombia’s Largest Coffeehouse Chain https://mjshareholders.com/flora-growth-begins-product-sales-in-juan-valdez-colombias-largest-coffeehouse-chain/ Tue, 21 Feb 2023 16:51:25 +0000 https://cannabisfn.com/?p=2972685

Ryan Allway

February 21st, 2023

News, Top News


– Procafecol S.A., the parent company of Juan Valdez, one of the most well-known Colombian coffee brands, signed an agreement with Flora to supply Juan Valdez coffee shops with Flora’s consumer goods products.

– The agreement allows Flora to distribute into 313 stores, with national distribution in Colombia.

FORT LAUDERDALE, Fla. & TORONTO, February 21, 2023–(BUSINESS WIRE)–Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading cultivator, manufacturer and distributor of global cannabis products and brands, announced today it has successfully begun distribution of its House of Brands product offering through the Juan Valdez coffeehouse chain. The agreement was signed with Procafecol S.A., the parent company of Juan Valdez, the world’s most well-known Colombian coffee brand and the largest chain of coffeehouses in Colombia.

Via this agreement, Flora’s products will be distributed in Colombia, where the Juan Valdez chain has more than 300 outposts selling Colombian coffee grown by a federation of 500,000 local farmers and other locally sourced drinks and food items. Flora’s natural fruit juice brand, Mambe, is the initial offering in-store and can now be found in 286 Juan Valdez locations.

“We are very proud to partner with the Juan Valdez brand to bring Flora products to market in the largest coffeehouse chain in Colombia,” said Luis Merchan, Chairman and CEO of Flora. “Our House of Brands division continues to focus on expanding our distribution network in Colombia and around the world. This partnership adds nearly 300 points of sale to our existing list of 15,000 doors globally and makes our products available in one of the most popular chains in Colombia.”

The agreement was finalized with Procafecol S.A. in December and allows Flora to distribute products to the 313 Juan Valdez coffeehouses in Colombia.

To learn more about Mambe juices or to view Flora Growth’s distributor form, please visit: https://www.floragrowth.com/services/mambe/.

About Flora Growth Corp.

As the operator of one of the largest cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house of brands, and life sciences divisions. Visit www.floragrowth.com or follow @floragrowthcorp on social media for more information.

Cautionary Statement Concerning Forward-Looking Statements

This press release contains ‘‘forward-looking statements,’’ as defined by federal securities laws. Forward-looking statements reflect Flora’s current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words “believe,” “expect,” “anticipate,” “will,” “could,” “would,” “should,” “may,” “plan,” “estimate,” “intend,” “predict,” “potential,” “continue,” and the negatives of these words and other similar expressions generally identify forward looking statements. Such forward-looking statements are subject to various risks and uncertainties, including those described under the section entitled “Risk Factors” in Flora’s Annual Report on Form 20-F filed with the SEC on May 9, 2022, as such factors may be updated from time to time in Flora’s periodic filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora’s filings with the SEC. While forward-looking statements reflect Flora’s good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based only on information currently available to Flora (or to third parties making the forward-looking statements).

View source version on businesswire.com: https://www.businesswire.com/news/home/20230221005427/en/

Contacts

Investor Relations:
ir@floragrowth.com

Public Relations:
Cassandra Dowell
+1 (858) 221-8001
flora@cmwmedia.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
Global Medical Cannabis Leader Khiron Opens New Zerenia™ Clinic and Retail Pharmacy in Colombia https://mjshareholders.com/global-medical-cannabis-leader-khiron-opens-new-zerenia-clinic-and-retail-pharmacy-in-colombia/ Mon, 11 Apr 2022 22:15:40 +0000 https://www.cannabisfn.com/?p=2943643

Ryan Allway

April 11th, 2022

News, Top News


Continues market leadership in ColombiaLatin America’s only country with universal health coverage for medical cannabis

  • Market leader in the Colombian medical cannabis market, with Q1 2022 volume sales exceeding 21,400 units, up 280% YoY and more than 40% of all 2021
  • New clinic continues Khiron’s unique patient acquisition and retention strategy, adding more than 20% of patient capacity to existing network
  • Located in El Ensueño shopping mall in Bogota, adjacent to various insurer´s referral centers. In Q1 2022, more than 85% of all patients receiving Khiron´s medical cannabis products in Colombia were covered by insurance programs
  • Opens its first retail pharmacy, fully licensed to dispense High and Low THC medical cannabis products to patients outside the Company´s own clinic network

TORONTOApril 11, 2022 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN)(OTCQX:KHRNF)(Frankfurt:A2JMZC), a global medical cannabis leader with core operations in Latin America and Europe, is pleased to announce the opening of a new Zerenia™ clinic location and a new retail pharmacy in Colombia.

Following the announcement at the beginning of the year by the Government of Colombia on mandatory insurance coverage for medical cannabis products, Khiron opens a new clinic location in the city of Bogota, with a maximum annual capacity of 40,000 consults per year. The new clinic, located in El Ensueño shopping mall in Bogota´s fastest growing districts with more than 850,000 people, will allow the Company to continue is market leadership in Colombia and offer more services to existing and current patients.

In addition, the Company has opened its first retail pharmacy location within this shopping center. This pharmacy will allow the Company to sell medical cannabis products to patients outside its own ZereniaTM network and dispense High and Low THC medical cannabis to insurance companies in the country.

Alvaro Torres, Khiron CEO and Director comments, “Khiron has become a clear leader in the Colombian medical cannabis market because of its unique go-to-market strategy, anchored in our ZereniaTM clinic model. This new expansion within Bogota capitalizes on the Colombian government’s decision on mandatory insurance coverage, and we aim to get closer to our patients and insurers, to improve quality of life. With our new retail pharmacy, we aim to be able to offer more access to patients outside our clinic network and to provide a dispensing alternative to insurers, thereby increasing our market leadership within Colombia. As we continue to grow, our leadership is expanding to Latin America and Europe, thanks to our ability to generate evidence, offer high quality products, and create an excellent patient-focused healthcare service that improves quality of life”.

About Khiron Life Sciences Corp.

Khiron is a leading integrated international medical cannabis company with core operations in Latin America and Europe. Leveraging medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, and high-quality product portfolio, to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in ColombiaPeruGermany, UK, and Brazil and is positioned to commence sales in Mexico. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.

Visit Khiron online at investors.khiron.ca

Linkedin https://www.linkedin.com/company/khiron-life-sciences-corp/

Cautionary Notes

Forward-Looking Statements

This press release may contain certain “forward-looking information” and “forward-looking statements” within the meaning of applicable securities legislation. All information contained herein that is not historical in nature may constitute forward-looking information. Khiron undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of Khiron, its securities, or financial or operating results (as applicable). Although Khiron believes that the expectations reflected in forward-looking statements in this press release are reasonable, such forward-looking statement has been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond Khiron’s control, including the risk factors discussed in Khiron’s Annual Information Form which is available on Khiron’s SEDAR profile at www.sedar.com. The forward-looking information contained in this press release is expressly qualified by this cautionary statement and is made as of the date hereof. Khiron disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.

Global Medical Cannabis Leader Khiron Opens New ZereniaTM Clinic and Retail Pharmacy in Colombia (CNW Group/Khiron Life Sciences Corp.)
Global Medical Cannabis Leader Khiron Opens New ZereniaTM Clinic and Retail Pharmacy in Colombia (CNW Group/Khiron Life Sciences Corp.)
Global Medical Cannabis Leader Khiron Opens New ZereniaTM Clinic and Retail Pharmacy in Colombia (CNW Group/Khiron Life Sciences Corp.)
Global Medical Cannabis Leader Khiron Opens New ZereniaTM Clinic and Retail Pharmacy in Colombia (CNW Group/Khiron Life Sciences Corp.)
Khiron Life Sciences Corp (CNW Group/Khiron Life Sciences Corp.)
Khiron Life Sciences Corp (CNW Group/Khiron Life Sciences Corp.)

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
Flora Growth Recognizes Colombia’s Completion of Cannabis Flower Export Rules, Prepares First Export Under New Regulations https://mjshareholders.com/flora-growth-recognizes-colombias-completion-of-cannabis-flower-export-rules-prepares-first-export-under-new-regulations/ Mon, 04 Apr 2022 17:40:37 +0000 https://www.cannabisfn.com/?p=2942867

Ryan Allway

April 4th, 2022

News, Top News


  • Colombia completes required regulations to allow Colombian cannabis companies, including Flora Growth, to export THC and CBD dried flower globally
  • Flora Growth reaffirms its ability to produce 43.6 tonnes of low-cost THC and CBD production costs of 6 cents per gram of dried flower along with full extraction and isolation capabilities at its Colombian cannabis cultivation facility

MIAMI & TORONTO, April 04, 2022–(BUSINESS WIRE)–Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to recognize Colombia’s final passing of all necessary checklists to permit the sale of THC and CBD dried flower to international markets via Resolution 539.

On April 1, the Government of Colombia finalized the cannabis flower regulatory checklist under Resolution 539 permitting licensed cannabis cultivators with export quotas, including Flora, to pass a mandatory approval process for the export of both CBD and THC flower. These export steps include adjustments to Flora’s approved 43.6-tonne quota, which allows the addition of dried flower to be included with all existing purchase agreements from countries including Germany, Israel, Australia, South Africa, Portugal, and Malta. This update also includes the requirement for genetics registrations attached to all high THC cultivars. Before the passage of this update, Flora Growth’s export quota already permitted the export of derivative products produced at its cultivation facility.

“Flora applauds the recent announcement by the Colombian Government as we have been working diligently to have all the necessary approvals and capabilities available to produce high THC flower, including multiple cannabis strains with THC levels over 20 percent,” said Jason Warnock, Flora’s Chief Commercial Officer. “This resolution also clears the path to export dried CBD flower to markets including the United States where Flora already sell hundreds of CBD products via owned brands like JustCBD, MIND, and Mambe.”

Flora maintains a low cost of cultivation of approximately 6 cents per gram on its fully integrated 254-acre licensed cannabis farm, Cosechemos, that includes on-site cryo-ethanol extraction, advanced drying systems, sterilization and cannabinoid isolation systems, and advanced testing within the onsite laboratory. The Cosechemos facility uses only organic farming cultivation techniques and is currently capable of producing 600 kg of dried cannabis daily, as well as over 10,000 kg of cannabis derivatives annually under EU-GMP guidelines.

With the passage of resolution 539, Flora can now include shipments of dried cannabis flower with derivatives exports including to its subsidiaries Flora Lab in Bogota, Colombia, and JustCBD in Fort Lauderdale, Florida, completing the vertical integration of certain Flora portfolio products including its CBD edible, topicals, and other infused products.

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands that is designed to deliver one of the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. Visit www.floragrowth.com or follow @floragrowthcorp on social for more information.

Cautionary Statement Concerning Forward-Looking Statements

This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: expected future revenue, the proposed acquisition of Vessel; Vessel’s financial performance; our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, or the forward-looking events discussed in this document and other statements made from time to time by us or our representatives not occurring, except as may be required by applicable law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220404005388/en/

Contacts

Investor Relations:
James Williams
[email protected]

Public Relations:
Cassandra Dowell
+1 (858) 264-6600
[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
Colombia Cannabis Market “Economic Impact Assessment” Released by CannabCo https://mjshareholders.com/colombia-cannabis-market-economic-impact-assessment-released-by-cannabco/ Fri, 25 Feb 2022 17:34:40 +0000 https://www.cannabisfn.com/?p=2938838

Working with its partners in Colombia, CannabCo has compiled an economic assessment report related to their operations in Colombia.  The report outlines CannabCo’s 5 major projects in relation to their economic impact on each region of operation.  Three of the operations are in the Cundinamarca region approximately one hour outside Bogota, the country’s capital, while the remaining two projects are located in the Meta region in the area around Villavicensio.

Colombia has made a significant commitment to the cannabis industry and industry experts are looking at the country as the hotspot for cannabis production moving forward.  “The commitment by all levels of government will provide a much needed economic boost in light of global setbacks from the recent COVID-19 pandemic”. Said Phillip Chen, the company’s Chief Business Development Officer.  “We are currently working closely with all key levels of Colombia’s government to provide the much needed economic stimulation to the economy”.

Colombian agricultural efforts in past years have taken a hit from rising costs of agricultural inputs such as fuel and fertilizer, and further suffered from third world global competition in certain food and flower exports.  Focusing on a relatively high value crop in a global emerging market would provide the much needed economic stimulus to the Colombian agricultural sector.

The company is involved with many initiatives in areas involving economic, social, and environmental impact as part of its core mandates in Colombia.  In the areas of job creation alone CannabCo estimates the creation of 1500 jobs over a 5 year period associated with its current 5 projects, and over double that number when accounting for ancillary work associated with the initiatives.  “Estimates from maturing cannabis markets in North America provide a fairly accurate economical and employment model which can be superimposed on the emerging Colombia cannabis industry” says CannabCo’s management.  “Impacted areas such as pharmaceutical, distribution, logistical support, transport, agricultural supply chain, and packaging are just a few of the industries surrounding the growth of cannabis in Colombia“.

The company further participates in community outreach programs in each of its operating regions including educational and social programs designed to train workers in agricultural practices and cannabis-centric skilled employment positions.

Recently the company announced the pending installation of one of South America’s most advanced extraction lines as part of its processing operation outside Bogota.  CannabCo is feels this will help Colombia’s efforts in becoming a world leader in Cannabis supply and further stimulate the economy.

About CannabCo Pharmaceutical Corp. Colombia S.A.S.
CannabCo Colombia is a Colombia based full service cannabis company with cultivation projects in multiple regions across the country. The company’s primary extraction plant is located 30 minutes outside the capital city of Bogota. The company will process both psychoactive and non-psychoactive cannabis and Hemp flower for the production of THC and CBD oil for the medical cannabis market.  The Company’s state of the art production facilities will have the capability of producing a wide range of end products to meet emerging market supply requirements for Colombia’s evolving cannabis industry, as well as global export. The facility is pursuing EU GMP status allowing access to the underserviced global pharmaceutical market. The company currently has multiple social projects as part of its ethical standards and is committed to the highest quality production of medical grade cannabis products in the industry. The company is vertically integrated controlling all aspects of cultivation, extraction, product manufacturing, and distribution of its medical products allowing it full control over the high quality of its end products. The company intends to be the largest producer and manufacturer of THC/CBD based products on a global scale utilizing Colombia as its operating base.

Forward Looking Statements
This press release may contain certain “forward-looking information” and “forward-looking statements” within the meaning of applicable securities legislation. All information contained herein that is not historical in nature may constitute forward-looking information. Forward-looking statements may be identified by  statements containing the words “believes”, “anticipates”, “plans”, “intends”, “will”, “should”, “expects”, “continue”, “estimate”, “forecasts” and other similar expressions. Actual results and developments may differ materially from those contemplated by these statements. Although CannabCo Colombia believes that the expectations reflected in forward-looking statements in this press release are reasonable, there can be no assurance that such statements will prove to be accurate. Future events and results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements in this press release.

SOURCE CannabCo Pharmaceutical Corp. Colombia S.A.S

For further information: Investor Relations: [email protected]; www.cannabco.co

]]>
One World Products Announces the Addition of Jim Hackney to Advisory Board as Chief Global Strategist https://mjshareholders.com/one-world-products-announces-the-addition-of-jim-hackney-to-advisory-board-as-chief-global-strategist/ Tue, 25 Jan 2022 23:13:11 +0000 https://www.cannabisfn.com/?p=2936745

Ryan Allway

January 25th, 2022


In His Role, Mr. Hackney Will Focus on International Initiatives and Affairs as One World Seeks to Expand its Global Platform of Sustainable Hemp and Cannabis Solutions

Mr. Hackney Joins Recently Appointed Board Chair Minyon Moore in Strengthening Company’s Advisory Board; Both Will Drive One World’s Global Expansion Efforts into New Markets and Sectors

LAS VEGAS, Jan. 25, 2022 (GLOBE NEWSWIRE) — One World Products, Inc. (OTC: OWPC) (“One World” or the “Company”), the largest Black-controlled, fully-licensed cannabis and hemp producer in Colombia, today announces the addition of Jim Hackney to its Advisory Board. Mr. Hackney will serve as Chief Global Strategist on the Advisory Board and will be instrumental in leading the Company’s international initiatives as One World seeks to expand its global platform of sustainable hemp and cannabis solutions.

Mr. Hackney will also serve as the lead advisor for One World’s continued build-out of prominent investment partnerships globally, and joins recently appointed Advisory Board Chair Minyon Moore. Both Mr. Hackney and Ms. Moore will be instrumental in driving One World’s expansion efforts into multiple industries and markets. Ms. Moore will also lead the Company’s efforts evaluating various global supplier diversity initiatives like the recent Stellantis National Black Supplier Development Program. One World Products was recently selected by Stellantis N.V., one of the world’s largest automotive manufacturers with brands such as Chrysler, Dodge, Fiat, Maserati, and Peugeot – to develop and supply hemp-based bioplastic solutions for interior and exterior components as part of the National Black Supplier Development Program. The Program is a joint initiative of Stellantis and the National Business League (NBL) and is the nation’s first black supplier development program.

“The addition of Jim Hackney to our Advisory Board as Chief Global Strategist is a tremendous accomplishment for One World. Jim has been a leader, duly representing the United States for more than 40 years in several capacities in the world of international investment, finance and trade,” commented Isiah Thomas, Executive Chairman and CEO of One World. “Jim’s experience and counsel in international trade, business, and finance will be invaluable as we tackle the challenges of becoming a leader in the global hemp and cannabis economy,” continued Mr. Thomas.

“The global opportunities for commercial hemp and cannabis have only just begun to be realized. I believe the recently-announced initiative with Stellantis is an early example of the potential applications for commercial hemp in industries around the world,” stated Mr. Hackney. “I am proud to be representing One World in expanding their sustainable hemp and cannabis platform into new geographies and sectors. I believe their vertically-integrated business model and their environmentally- and socially-focused approach is distinctive, and demonstrates the leadership that we will only continue to underscore moving forward,” continued Mr. Hackney.

Mr. Hackney is a Principal and Co-Founder of Inergix Corporation, a global consulting and advisory services firm established in 2014 to service clients in the energy, healthcare, technology and security industries. As of November 1, 2021, Mr. Hackney has also assumed the role of Chief Global Strategy and Investment Officer of ISIAH INTERNATIONAL, a holding company with domestic and foreign interests in a diversified portfolio of companies founded by the legendary Hall of Fame basketball great Isiah Lord Thomas III.

Mr. Hackney served in the Administrations of President Jimmy Carter and President Bill Clinton. During the Clinton Administration, he served as Counselor to the Secretary of Commerce, Ronald H. Brown. As one of the Secretary’s closest and most trusted advisers, Mr. Hackney helped to devise and implement the Commercial Diplomacy Program, which was principally responsible for the awarding of $50 billion in infrastructure contracts to U.S. firms by the governments of Saudi Arabia, Mexico, China, India, Brazil, Argentina, Turkey, Egypt and South Africa. In addition, Mr. Hackney co-managed programs that provided aid, business opportunities, and access for small businesses and women- and minority-owned businesses to domestic and international markets.

As a U.S. State Department legal adviser during the Carter years, Mr. Hackney negotiated several bilateral investment agreements, including those with China, Egypt, Morocco, Jamaica, Panama and Malaysia. His portfolio also included advising the State Department’s policy officers on legal matters involving the World Bank, the International Monetary Fund (IMF), U.S. Export Import Bank (EXIM), the Overseas Private Investment Corporation (OPIC) and the US Committee on Foreign Investment in the U.S. (CFIUS).

During his career, Mr. Hackney has also been a member of two highly recognized global law firms. During his tenure at White and Case, he was a member of the firm’s Sovereign Practice Group. In this capacity, he advised the Governments of Egypt, Morocco, Jordan, Turkey and Indonesia on their financial and commercial transactions with the OECD member states, the World Bank, the IMF and the major global banking institutions. In addition, Mr. Hackney provided legal counsel and advice on a range of infrastructure project financings, foreign military sales transactions, and privatizations of state-owned enterprises.

In addition to his international corporate practice, throughout his career, Mr. Hackney has been engaged in substantial pro bono legal work on behalf of the Democratic National Committee, the Lawyers Committee for Civil Rights Under Law, Trans Africa, the American Society of International Law, the Robert F. Kennedy Human Rights Foundation and the Center for Law and Social Policy.

Mr. Hackney holds a B.A. in Political History and a J.D. law degree from the University of Pennsylvania. He has served on the boards of public and private companies, and nonprofit organizations.

About One World Products
One World Products is the largest Black-controlled, fully licensed cannabis and hemp producer with offices in Las Vegas, Nevada and offices and operations in Bogota and Popayan, Colombia. One World Products planted its first crop of cannabis in 2018 at its cultivation site in Popayan, Colombia, and began harvesting commercially in the first quarter of 2020. The company expects to supply its global clients with the highest quality industrial and commercial applications for cannabis, hemp and hemp products, including derivatives in crude oil, distillate, and isolate forms with industrial scale production to serve global cannabis and hemp demand. Its products will be produced and tested to GAP, GMP and ISO standards.

One World Products was recently selected by Stellantis N.V., one of the world’s largest automotive manufacturers with brands such as Chrysler, Dodge, Fiat, Maserati, and Peugeot – to develop and supply hemp-based bioplastic solutions for interior and exterior components.

As its name suggests, One World is also focused on environmental, social and governance (ESG) standards, with particular emphasis on its impact on the environment as well as ensuring that its employees, particularly those within its Colombia operations, are valued and recognized for their contributions, while simultaneously maintaining stewardship over their indigenous land.

Contact:

CORE IR
Matt Blazei
516-386-0430
[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>